Literature DB >> 1448309

Value of C-reactive protein determination in the initial diagnostic evaluation of the febrile, neutropenic child with cancer.

J A Katz1, M M Mustafa, R O Bash, J V Cash, G R Buchanan.   

Abstract

We studied prospectively the value of administration C-reactive protein (CRP) in the diagnostic evaluation of the child with cancer hospitalized for fever and neutropenia. During a 7-month period 74 patients with malignant disease had 122 hospital admissions because of fever and neutropenia. All patients had a serum CRP obtained 8 to 24 hours after the onset of fever as part of their initial evaluation. There was a borderline correlation between serum CRP concentration and temperature at admission (P = 0.06). Patients with fever without an identifiable source had significantly lower CRP concentrations compared with those having focal or microbiologically documented infection (34.9 +/- 6 vs. 70.2 +/- 12 mg/liter; P = 0.0005). Twelve patients had positive blood cultures, 5 of which were coagulase-negative staphylococci considered to be central venous catheter-related infection or colonization. CRP concentrations were significantly lower in these 5 patients compared with the 7 patients with septicemia caused by other organisms (21 +/- 9 vs. 113 +/- 23 mg/liter; P = 0.01). In distinguishing between septicemic and nonsepticemic children, serum CRP was found to have excellent sensitivity and negative predictive value at concentration limits of 20, 50 and 100 mg/liter. However, both specificity and positive predictive value were low at these respective levels, thus limiting the overall utility of serum CRP in the initial empiric management of the febrile, neutropenic child with cancer.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1448309     DOI: 10.1097/00006454-199209000-00007

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  12 in total

1.  Control and duration of therapy in complicated UTI--with special consideration of C-reactive protein.

Authors:  D Höffler
Journal:  Infection       Date:  1994       Impact factor: 3.553

2.  An analysis of interleukin-8, interleukin-6 and C-reactive protein serum concentrations to predict fever, gram-negative bacteremia and complicated infection in neutropenic cancer patients.

Authors:  A Engel; E Mack; P Kern; W V Kern
Journal:  Infection       Date:  1998 Jul-Aug       Impact factor: 3.553

3.  Cytokine concentrations are not predictive of bacteremia in febrile neutropenic patients.

Authors:  Nuray Buyukberber; Süleyman Buyukberber; Alper Sevinc; Celalettin Camci
Journal:  Med Oncol       Date:  2008-08-07       Impact factor: 3.064

4.  Plasma levels of IL-1, TNF alpha, IL-6, IL-8, G-CSF, and IL1-RA during febrile neutropenia: results of a prospective study in patients undergoing chemotherapy for acute myelogenous leukemia.

Authors:  H Schönbohn; M Schuler; K Kolbe; C Peschel; C Huber; W Bemb; W E Aulitzky
Journal:  Ann Hematol       Date:  1995-10       Impact factor: 3.673

5.  Procalcitonin and C-Reactive Protein As Markers of Bacteremia in Patients With Febrile Neutropenia Who Receive Chemotherapy for Acute Leukemia: A Prospective Study From Nepal.

Authors:  Ramila Shilpakar; Bishnu Dutta Paudel; Prakash Neupane; Aarati Shah; Bibek Acharya; Soniya Dulal; Lori Anne Wood; Rukmani Shahi; Usha Khanal; Bishesh Sharma Poudyal
Journal:  J Glob Oncol       Date:  2019-09

6.  The diagnostic value of CRP, IL-8, PCT, and sTREM-1 in the detection of bacterial infections in pediatric oncology patients with febrile neutropenia.

Authors:  Karin G E Miedema; Eveline S J M de Bont; Rob F M Oude Elferink; Michel J van Vliet; Claudi S M Oude Nijhuis; Willem A Kamps; Wim J E Tissing
Journal:  Support Care Cancer       Date:  2010-08-28       Impact factor: 3.603

Review 7.  Systematic review and meta-analysis of the value of initial biomarkers in predicting adverse outcome in febrile neutropenic episodes in children and young people with cancer.

Authors:  Robert S Phillips; Ros Wade; Thomas Lehrnbecher; Lesley A Stewart; Alex J Sutton
Journal:  BMC Med       Date:  2012-01-18       Impact factor: 8.775

8.  Procalcitonin (PCT) and C-reactive protein (CRP) as severe systemic infection markers in febrile neutropenic adults.

Authors:  Karin S R Massaro; Silvia F Costa; Claudio Leone; Dalton A F Chamone
Journal:  BMC Infect Dis       Date:  2007-11-22       Impact factor: 3.090

9.  Procalcitonin and C-reactive protein in the diagnosis and prediction of spontaneous bacterial peritonitis associated with chronic severe hepatitis B.

Authors:  Le-Yong Yuan; Zun-Qiong Ke; Ming Wang; Yan Li
Journal:  Ann Lab Med       Date:  2013-10-17       Impact factor: 3.464

10.  Performance of Interleukin-6 and Interleukin-8 serum levels in pediatric oncology patients with neutropenia and fever for the assessment of low-risk.

Authors:  Miriam Diepold; Peter Noellke; Ulrich Duffner; Udo Kontny; Reinhard Berner
Journal:  BMC Infect Dis       Date:  2008-03-06       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.